Given the current situation, we understand that people may experience worry and even fear about how their disease and treatment may impact their personal risk. Sanofi Genzyme is committed to patient safety and to transparent communication. We are taking COVID-19 seriously, and we are committed to updating the communities we serve with relevant information related to our medicines to help inform health decisions.
As COVID-19 has emerged only recently, there are no available data regarding the impact of the virus on our current therapies. At this time, if you have general questions about our therapies, you should consult the current U.S Prescribing Information (USPI).
Each patient’s situation is unique, and patients and their healthcare providers are in the best position to make decisions regarding their care. In addition to local public health authority guidance, and local guidance from medical or patient associations, more information about COVID-19 can be found on the Centers for Disease Control’s (CDC) website or the World Health Organization’s (WHO) website.
MAT-US-2001115
Packed with Mediterranean recipes that have been handpicked for their low-fat, high-fiber content, A Fresh Start is a delicious, heart-healthy way to welcome you to the Common Threads community.
image copyright Baldwin Publishing
It's a welcoming and supportive community for people living with relapsing MS who have been prescribed AUBAGIO (teriflunomide) and their care partners. Members get access to:
An informational program for people just beginning treatment on AUBAGIO.
Monthly topics focused on living well, keeping positive, and hearing from others.
Community members share their experiences, stories, tips, hope, and inspiration.
Learn about the shared experiences that tie
Common Threads members together —
providing hope, purpose, and
community to all.
ASHLEY
Member
Being a member of this community is important to me because I need all of you to help me maintain my happy, functional, normal life. My family is amazing; they are supportive, caring, loving and always there for me. They are also the ones who worry, get scared and they have never experienced what I’m going through. By belonging to this community, I get to connect with others, hear stories and communicate with people who know what I am experiencing because they are living it to. My family doesn’t need to be worried or scared when I need to talk. I just need to belong to a group of people who care, listen, give personal experiences and who know what I am going through; this community can provide all of that.
- Anonymous
Get easy-to-read (and print) information on AUBAGIO. From financial assistance to family planning, these guides can answer many questions.
Contact an MS One to One® Nurse at 1‑855‑676-6326
Whether you're just starting out on AUBAGIO® or have been taking it for a while MS One to One is here for you. Once you've been prescribed AUBAGIO, MS One to One can help with benefit verification or side effect support, or can just be someone to talk to that can understand your experiences with relapsing MS.
Do not take AUBAGIO if you have severe liver problems. AUBAGIO may cause serious liver problems, which can be life-threatening. Your risk may be higher if you take other medicines that affect your liver. View More
AUBAGIO® (teriflunomide) is a prescription medicine used to treat relapsing forms of multiple sclerosis (MS), to include clinically isolated syndrome, relapsing-remitting disease, and active secondary progressive disease, in adults.
Are of childbearing potential and not using effective birth control.
It is not known if AUBAGIO passes into breast milk. Your healthcare provider can help you decide if you should take AUBAGIO or breastfeed — you should not do both at the same time.
If you are a man whose partner plans to become pregnant, you should stop taking AUBAGIO and talk with your healthcare provider about reducing the levels of AUBAGIO in your blood. If your partner does not plan to become pregnant, use effective birth control while taking AUBAGIO.
AUBAGIO may stay in your blood for up to 2 years after you stop taking it. Your healthcare provider can prescribe a medicine that can remove AUBAGIO from your blood quickly.
Before taking AUBAGIO, talk with your healthcare provider if you have: liver or kidney problems; a fever or infection, or if you are unable to fight infections; numbness or tingling in your hands or feet that is different from your MS symptoms; diabetes; serious skin problems when taking other medicines; breathing problems; or high blood pressure. Your healthcare provider will check your blood cell count and TB test before you start AUBAGIO. Talk with your healthcare provider if you take or are planning to take other medicines (especially medicines for treating cancer or controlling your immune system), vitamins or herbal supplements.
AUBAGIO may cause serious side effects, including: reduced white blood cell count — this may cause you to have more infections; numbness or tingling in your hands or feet that is different from your MS symptoms; allergic reactions, including serious skin problems; breathing problems (new or worsening); and high blood pressure. Patients with low white blood cell count should not receive certain vaccinations during AUBAGIO treatment and 6 months after.
Tell your doctor if you have any side effect that bothers you or does not go away.
The most common side effects when taking AUBAGIO include: headache; diarrhea; nausea; hair thinning or loss; and abnormal liver test results. These are not all the side effects of AUBAGIO. Tell your healthcare provider about any side effect that bothers you.
Consult your healthcare provider if you have questions about your health or any medications you may be taking, including AUBAGIO.
Please click here for full Prescribing Information, including boxed WARNING and Medication Guide.